Non-Surgical Orthopedic Clinic Texas: The 6-City Access Map That Closes the State’s Orthopedic Supply Gap

Introduction: Texas Has an Orthopedic Crisis — And a 6-City Solution

Texas presents a troubling paradox in orthopedic care. The state ranks second in the nation with 2,014 active orthopedic surgeons, yet holds a normalized supply score of 0 and a Relative Demand Index of 83 out of 100—the worst supply-demand gap in the country, according to 2025 research published in the Online Journal of Public Health Informatics.

The human stakes are substantial. An estimated 126.6 million Americans—one in two adults—live with a musculoskeletal condition, more than double those with chronic heart and lung conditions combined. Texas’s rapidly growing and aging population amplifies this burden disproportionately, creating a healthcare access challenge that traditional surgical pathways cannot solve alone.

This article serves as a data-backed decision framework for Texans seeking non-surgical orthopedic care. It maps where to find treatment across the state, explains what patients can expect, and demonstrates why non-surgical intervention represents the medically sound first step—not a fallback option.

Unicorn Bioscience operates a six-location Texas footprint spanning Austin, Dallas, El Paso, Fort Worth, Houston, and San Antonio. This geographic distribution represents a structural response to the state’s documented access gap, positioning non-surgical orthopedic care where Texans actually live and work.

The Texas Orthopedic Supply-Demand Gap: What the Data Actually Shows

The 2025 PubMed/UT Health San Antonio study reveals a stark reality: despite ranking second in raw surgeon count, Texas scores zero on normalized orthopedic surgeon concentration. Population size simply overwhelms supply.

The Relative Demand Index (RDI) of 83 out of 100 measures patient demand for orthopedic care by region using Google Trends data. Texas’s score signals critical unmet need—patients are actively searching for care they cannot readily access.

The Health Resources and Services Administration (HRSA) projected a nationwide shortage of 5,080 orthopedic surgeons by 2025. Becker’s Spine Review reports that supply is expected to fall 2% while demand rises up to 13% by 2036, according to research published in the Journal of the American Academy of Orthopaedic Surgeons.

Demographics drive this demand surge. Adults over 65 represent only 17.3% of the U.S. population but generate 37% of diagnostic tests and 34% of inpatient procedures. Texas’s senior population is growing rapidly, intensifying pressure on an already strained system.

For patients, this translates to long wait times, limited appointment availability, and geographic concentration of surgeons in urban cores—leaving millions of Texans without timely orthopedic access. This supply gap is precisely why non-surgical orthopedic clinics represent a structural necessity for Texas’s healthcare system.

Why Non-Surgical Orthopedic Care Is the Medically Sound First Step

Non-surgical treatments—including physical therapy, PRP, hyaluronic acid injections, corticosteroid injections, bracing, and lifestyle modification—constitute the recognized first line of care before surgery is considered. This is not alternative medicine; it is standard clinical practice.

The surgery overuse problem warrants attention. Up to 80% of patients told they need total knee replacement may not actually require surgery, while over 600,000 knee replacements are performed annually in the United States. These numbers suggest a significant population receiving surgical recommendations who could benefit from conservative care first.

2025 research published in PMC demonstrates that PRP shows significantly better pain and function scores than both corticosteroids and hyaluronic acid at 6- and 12-month follow-ups for knee osteoarthritis, rotator cuff tendinopathy, and lateral epicondylitis.

The risk-benefit calculus favors non-surgical approaches for mild-to-moderate conditions. These treatments carry fewer risks, require no general anesthesia, eliminate surgical site infection risk, and offer dramatically shorter recovery times.

Nearly $213 billion is spent annually in the U.S. on treatment, care, and lost wages related to musculoskeletal conditions, averaging $7,800 per person. Cost-effective non-surgical care serves both personal and systemic financial imperatives.

Regulatory transparency matters: as of 2026, the FDA has not approved stem cell, PRP, or exosome products specifically for orthopedic conditions. However, substantial clinical evidence supports their safety and efficacy when administered by qualified providers within FDA regulatory frameworks—a disclosure Unicorn Bioscience makes openly.

The 6-City Access Map: Unicorn Bioscience’s Texas Footprint

Each Unicorn Bioscience location functions as a deliberate access point in a state where orthopedic care is chronically undersupplied. All six locations share the same non-surgical-first philosophy, multi-modal treatment menu, precision imaging-guided injections, and same-day treatment availability for qualified patients.

This model represents a structural advantage. Most Texas orthopedic competitors concentrate in a single metro area or blend surgical and non-surgical messaging. A six-city, exclusively non-surgical network cannot be easily replicated by single-location providers.

Austin: 2501 W William Cannon Dr STE 208, Austin, TX 78745

Austin’s tech-driven economy and outdoor-activity culture generate high rates of sports-related injuries and joint conditions, creating sustained demand for orthopedic services.

Surgical-forward competitors are present in the Austin market, but Unicorn Bioscience’s non-surgical-exclusive positioning fills a distinct niche for patients specifically seeking conservative treatment.

Common conditions treated at this location include knee osteoarthritis, rotator cuff injuries, tendinopathies, and sports-related ligament conditions. Virtual consultations extend access to patients in surrounding Central Texas communities.

Dallas: 6200 Lyndon B Johnson Fwy Suite 180, Dallas, TX 75240

Dallas represents the state’s largest metro and a high-demand orthopedic market, where hospital-system overhead and surgical-forward competitors dominate the landscape.

Unicorn Bioscience’s Dallas location offers a personalized, non-surgical alternative to large hospital systems. The LBJ Freeway corridor location serves patients across the broader Dallas metro.

El Paso: 11240 Vista Del Sol Suite C, El Paso, TX 79936

El Paso holds unique significance as a border city geographically isolated from other major Texas metros. Residents historically face some of the most acute healthcare access challenges in the state.

El Paso and West Texas are among the regions most affected by orthopedic surgeon concentration in urban cores. Patients previously seeking regenerative orthopedic care often had to travel to San Antonio or Houston, or consider medical tourism across the border.

Unicorn Bioscience’s presence eliminates that barrier while offering U.S.-based, FDA-framework treatments—a meaningful differentiator for border communities historically exposed to unregulated overseas stem cell treatments.

Fort Worth: 3712 W 7th St, Fort Worth, TX 76107

Fort Worth maintains its own large population, active sports culture, and orthopedic demand that is often underserved relative to its DFW counterpart.

Single-location, single-physician non-surgical practices in Fort Worth face inherent capacity limitations. Unicorn Bioscience’s Fort Worth location offers broader treatment modalities, including PRP, stem cell therapy, exosomes, BMAC, hyaluronic acid, and peptides.

The West 7th Street location provides accessibility within one of Fort Worth’s most active commercial and residential corridors.

Houston: 12121 Richmond Ave., Suite #312, Houston, TX 77082

Houston’s massive, diverse patient population spans athletes, industrial workers, and a rapidly aging senior demographic. The city’s size paradoxically creates access challenges—large hospital systems dominate but often carry extensive wait times for specialist appointments.

The Richmond Avenue location in the Energy Corridor/Westside area serves Houston’s large suburban and professional population. Same-day treatment availability provides a critical differentiator in a high-volume market where patients often wait weeks for surgical consultations.

San Antonio: 115 Gallery Cir Suite 101, San Antonio, TX 78258

San Antonio hosts one of Texas’s largest veteran and military populations—a demographic with disproportionately high rates of musculoskeletal injuries and a strong preference for non-surgical care pathways.

Large surgical orthopedic groups operate in San Antonio, but Unicorn Bioscience offers a more focused, non-surgical-exclusive and regenerative medicine-forward alternative. The North San Antonio/Stone Oak location is strategically placed in one of the city’s fastest-growing suburban corridors.

What to Expect at a Unicorn Bioscience Non-Surgical Orthopedic Clinic

The care pathway follows a structured sequence: initial consultation (virtual or in-person), comprehensive assessment, personalized treatment planning, and same-day treatment for qualified candidates.

Treatment protocols are developed based on inflammation levels, patient age, injury type and location, current medications, and personal health goals. This is not a one-size-fits-all approach.

Precision-guided injection technology distinguishes Unicorn Bioscience from less-equipped providers. All injections are administered using ultrasound and/or X-ray imaging guidance to ensure accurate delivery to the targeted treatment area.

For patients who qualify, consultation and treatment can occur in a single visit—a significant advantage over surgical pathways requiring pre-operative workups, scheduling delays, and hospital admission. Virtual consultations extend accessibility to rural Texas patients or those with mobility limitations.

The Non-Surgical Treatment Menu: From PRP to Cellular Therapies

Rather than offering a single modality, Unicorn Bioscience provides a spectrum of non-surgical options that can be combined or sequenced based on individual patient needs.

Platelet-Rich Plasma (PRP) Therapy

PRP consists of concentrated platelets derived from the patient’s own blood, used to accelerate natural healing processes in damaged tissue. Clinical studies demonstrate PRP efficacy in managing knee osteoarthritis, rotator cuff tendinopathy, and lateral epicondylitis, often showing superior long-term benefits compared with conventional treatments.

Stem Cell Therapy and BMAC

Stem cell therapy and Bone Marrow Aspiration Concentrate (BMAC) use the body’s own regenerative cells to promote tissue repair in joints, tendons, and ligaments. Unicorn Bioscience reports that more than 90% of stem cell patients have not gone on to knee replacement surgery.

A January 2026 Phase III clinical trial funded with $140 million demonstrates the field’s growing scientific momentum, with 224 global trials currently underway investigating these therapies for osteoarthritis.

Exosome Therapy and Peptide Therapy

Exosomes are extracellular vesicles that facilitate cellular communication and may support tissue regeneration—a newer modality gaining traction in orthobiologics research. Peptide therapy involves targeted treatments designed to support tissue repair at the cellular level.

The orthobiologics market is projected to grow at a 10.22% CAGR through 2031, underscoring why these treatments represent the direction of orthopedic care.

Hyaluronic Acid Injections

Hyaluronic acid (viscosupplementation) is a well-established, FDA-recognized treatment for joint lubrication and pain relief, particularly for knee osteoarthritis. It serves as a foundational non-surgical option with a long clinical track record, often used in combination with PRP or cellular therapies for enhanced outcomes.

Conditions Treated: Is Your Orthopedic Problem a Candidate for Non-Surgical Care?

Common musculoskeletal conditions treated non-surgically include:

Shoulder/Elbow/Hand/Wrist: Rotator cuff injuries, tendinopathies, tennis elbow, carpal tunnel symptoms

Spine/Neck: Back pain, neck pain, disc-related conditions

Hip: Osteoarthritis, bursitis, labral conditions

Knee: Osteoarthritis, meniscus injuries, ligament sprains

Ankle/Foot: Plantar fasciitis, Achilles tendinopathy, ankle sprains

Most mild-to-moderate orthopedic conditions are appropriate for non-surgical first-line treatment. Same-day consultations can determine candidacy quickly, and athletes or active individuals benefit particularly from treatments that minimize downtime and support return to activity.

Conclusion: Closing the Gap, One City at a Time

Texas’s orthopedic supply-demand crisis is real, data-documented, and worsening. Non-surgical orthopedic clinics represent not a compromise but a medically sound, structurally necessary response.

The six-city access map—Austin, Dallas, El Paso, Fort Worth, Houston, and San Antonio—collectively represents the most geographically distributed non-surgical orthopedic footprint in Texas, designed to serve the state’s most underserved patient populations.

Choosing non-surgical care first is not giving up on treatment. It is making the evidence-based, clinically supported decision that the majority of orthopedic patients should make before considering surgery.

As Texas grows, its orthopedic access gap will not close through surgical capacity alone. It will close through accessible, evidence-informed, non-surgical care delivered where patients live.

Find the Nearest Unicorn Bioscience Location

Patients can book a consultation—virtual or in-person—at the location nearest to them:

• Austin: 2501 W William Cannon Dr STE 208, Austin, TX 78745
• Dallas: 6200 LBJ Fwy Suite 180, Dallas, TX 75240
• El Paso: 11240 Vista Del Sol Suite C, El Paso, TX 79936
• Fort Worth: 3712 W 7th St, Fort Worth, TX 76107
• Houston: 12121 Richmond Ave. Suite #312, Houston, TX 77082
• San Antonio: 115 Gallery Cir Suite 101, San Antonio, TX 78258

Phone: (737) 347-0446
Website: unicornbioscience.com

Qualified patients may receive treatment on the same day as their consultation. A consultation is a conversation, not a commitment—and for patients who have been told surgery is their only option, it may be the most important second opinion they ever seek.